| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8651008 | American Heart Journal | 2018 | 33 Pages |
Abstract
The PIONEER-HF trial will inform clinical practice by providing evidence on the safety, tolerability, and efficacy of in-hospital initiation of sacubitril/valsartan among patients who have been stabilized following an admission for acute decompensated HF with a reduced EF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Eric J. MD, David A. MD, MPH, Adam D. MD, MHS, Andrew P. MD, Carol I. DO, Kevin MA, Adrian F. MD, Ricardo A. MD, Eugene MD,